Pulse Biosciences Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Public

  • Employees
  • 116

Employees

  • Stock Symbol
  • PLSE

Stock Symbol

  • Share Price
  • $46.38
  • (As of Monday Closing)

Pulse Biosciences General Information

Description

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.

Contact Information

Formerly Known As
Electroblate
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 3957 Point Eden Way
  • Hayward, CA 94545
  • United States
+1 (833)
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Other Devices and Supplies
Therapeutic Devices
Stock Exchange
NAS
Vertical(s)
Corporate Office
  • 3957 Point Eden Way
  • Hayward, CA 94545
  • United States
+1 (833)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pulse Biosciences Stock Performance

As of 16-Nov-2026, Pulse Biosciences’s stock price is $46.38. Its current market cap is $3.41B with 73.5M shares.

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$46.38 $50.44 $12.56 - $58.94 $3.41B 73.5M 503K -$1.21

Pulse Biosciences Financials Summary

As of 30-Sep-2026, Pulse Biosciences has a trailing 12-month revenue of $1.49M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 3,465,577 843,125 1,000,339 633,184
Revenue 1,494 350 0 0
EBITDA (85,916) (75,920) (55,097) (42,367)
Net Income (83,722) (72,781) (53,585) (42,210)
Total Assets 201,584 94,539 132,460 59,154
Total Debt 6,363 7,530 8,898 9,144
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Pulse Biosciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Pulse Biosciences‘s full profile, request access.

Request a free trial

Pulse Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pul
Other Pharmaceuticals and Biotechnology
Hayward, CA
116 As of 2025

Hayward, CA
 

Danvers, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Pulse Biosciences Competitors (7)

One of Pulse Biosciences’s 7 competitors is RefleXion, a Venture Capital-Backed company based in Hayward, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
RefleXion Venture Capital-Backed Hayward, CA
Abiomed Corporate Backed or Acquired Danvers, MA
CardioFocus Venture Capital-Backed Marlborough, MA
Edwards Lifesciences Corporation Irvine, CA
ViewRay Formerly VC-backed Bedford, OH
You’re viewing 5 of 7 competitors. Get the full list »

Pulse Biosciences Patents

Pulse Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026165183-A1 Clamp-type electrode apparatuses and methods Pending 31-Jan-2025
WO-2026156323-A1 Isolation interface apparatuses and methods for high-voltage medical treatment Pending 16-Jan-2025
WO-2026117365-A1 Electrical applicator apparatuses and methods of use Pending 26-Nov-2024
WO-2026030164-A1 Conductive spacer in an electrode assembly of an electrical treatment apparatus Pending 29-Jul-2024
WO-2026015310-A1 Clamp electrodes forming gripping surfaces Pending 08-Jul-2024 A61B18/1445
To view Pulse Biosciences’s complete patent history, request access »

Pulse Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pulse Biosciences ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

36.26 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,592

Rank

Percentile

Healthcare

Industry

of 590

Rank

Percentile

Medical Devices

Subindustry

of 209

Rank

Percentile

To view Pulse Biosciences’s complete esg history, request access »

Pulse Biosciences FAQs

  • When was Pulse Biosciences founded?

    Pulse Biosciences was founded in 2014.

  • Where is Pulse Biosciences headquartered?

    Pulse Biosciences is headquartered in Hayward, CA.

  • What is the size of Pulse Biosciences?

    Pulse Biosciences has 116 total employees.

  • What industry is Pulse Biosciences in?

    Pulse Biosciences’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Pulse Biosciences a private or public company?

    Pulse Biosciences is a Public company.

  • What is Pulse Biosciences’s stock symbol?

    The ticker symbol for Pulse Biosciences is PLSE.

  • What is the current stock price of Pulse Biosciences?

    As of 16-Nov-2026 the stock price of Pulse Biosciences is $46.38.

  • What is the current market cap of Pulse Biosciences?

    The current market capitalization of Pulse Biosciences is $3.41B.

  • What is Pulse Biosciences’s current revenue?

    The trailing twelve month revenue for Pulse Biosciences is $1.49M.

  • Who are Pulse Biosciences’s competitors?

    RefleXion, Abiomed, CardioFocus, Edwards Lifesciences, and ViewRay are some of the 7 competitors of Pulse Biosciences.

  • What is Pulse Biosciences’s annual earnings per share (EPS)?

    Pulse Biosciences’s EPS for 12 months was -$1.21.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process